# Drug Repurposing Pathway Validation Configuration
# ===================================================
# Define your known drug repurposing pathways here for automated validation

pathways:
  - name: "thalidomide_multiple_myeloma"
    drug: "Thalidomide"
    disease: "multiple myeloma"
    mechanism_type: "protein_degradation"
    documented_source: "FDA approval 2006, Singhal et al. 1999"
    expected_pathway:
      - node: "Thalidomide"
        type: "drug"
      - node: "CRBN"
        type: "gene/protein"
        description: "Cereblon - E3 ubiquitin ligase component"
      - node: "protein ubiquitination"
        type: "biological_process"
      - node: "proteasome-mediated ubiquitin-dependent protein degradation"
        type: "biological_process"
    
  - name: "aspirin_myocardial_infarction"
    drug: "Aspirin"
    disease: "myocardial infarction"
    mechanism_type: "antiplatelet"
    documented_source: "Secondary prevention standard of care"
    expected_pathway:
      - node: "Aspirin"
        type: "drug"
      - node: "PTGS1"
        type: "gene/protein"
        description: "Cyclooxygenase-1 (COX-1)"
      - node: "platelet activation"
        type: "biological_process"
      - node: "thrombosis"
        type: "disease"
      - node: "myocardial infarction"
        type: "disease"
        
  - name: "sildenafil_pulmonary_hypertension"
    drug: "Sildenafil"
    disease: "pulmonary arterial hypertension"
    mechanism_type: "vasodilation"
    documented_source: "FDA approval 2005 (Revatio)"
    expected_pathway:
      - node: "Sildenafil"
        type: "drug"
      - node: "PDE5A"
        type: "gene/protein"
        description: "Phosphodiesterase 5A"
      - node: "cGMP signaling"
        type: "pathway"
      - node: "vasodilation"
        type: "biological_process"
      - node: "pulmonary arterial hypertension"
        type: "disease"
        
  - name: "metformin_polycystic_ovary"
    drug: "Metformin"
    disease: "polycystic ovary syndrome"
    mechanism_type: "insulin_sensitization"
    documented_source: "Common off-label use"
    expected_pathway:
      - node: "Metformin"
        type: "drug"
      - node: "AMPK"
        type: "gene/protein"
        description: "AMP-activated protein kinase"
      - node: "insulin signaling"
        type: "pathway"
      - node: "glucose metabolism"
        type: "biological_process"
      - node: "polycystic ovary syndrome"
        type: "disease"
        
  - name: "rituximab_rheumatoid_arthritis"
    drug: "Rituximab"
    disease: "rheumatoid arthritis"
    mechanism_type: "B_cell_depletion"
    documented_source: "FDA approval 2006"
    expected_pathway:
      - node: "Rituximab"
        type: "drug"
      - node: "CD20"
        type: "gene/protein"
        description: "B-lymphocyte antigen CD20"
      - node: "B cell activation"
        type: "biological_process"
      - node: "immune response"
        type: "biological_process"
      - node: "rheumatoid arthritis"
        type: "disease"

# Additional pathways to validate
# Add more entries following the same structure

validation_settings:
  check_alternative_names: true
  max_search_depth: 5
  min_coverage_threshold: 0.7
  fuzzy_matching: true
